41
Goetgebuer, R L, Kreijne, J E, Aitken, C A, Dijkstra, G, Hoentjen, F, de Boer, N K, Oldenburg, B, van der Meulen, A E, Ponsioen, C I J, Pierik, M J, van Kemenade, F J, de Kok, I M C M, Siebers, A G, Manniën, J, van der Woude, C J, de Vries, A C
Veröffentlicht in: Goetgebuer , R L , Kreijne , J E , Aitken , C A , Dijkstra , G , Hoentjen , F , de Boer , N K , Oldenburg , B , van der Meulen , A E , Ponsioen , C I J , Pierik , M J , van Kemenade , F J , de Kok , I M C M , Siebers , A G , Manniën , J , van der Woude , C J & de Vries , A C 2021 , ' Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease : A Case-controlled Cohort Study ' , Journal of Crohn's & Colitis , vol. 15 , no. 9 , pp. 1464-1473 . https://doi.org/10.1093/ecco-jcc/jjab036;
2021
Veröffentlicht in: Goetgebuer , R L , Kreijne , J E , Aitken , C A , Dijkstra , G , Hoentjen , F , de Boer , N K , Oldenburg , B , van der Meulen , A E , Ponsioen , C I J , Pierik , M J , van Kemenade , F J , de Kok , I M C M , Siebers , A G , Manniën , J , van der Woude , C J & de Vries , A C 2021 , ' Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease : A Case-controlled Cohort Study ' , Journal of Crohn's & Colitis , vol. 15 , no. 9 , pp. 1464-1473 . https://doi.org/10.1093/ecco-jcc/jjab036;
2021
42
43
44
Woestenberg, Petra J, King, Audrey J, van Benthem, Birgit H B, Donken, Robine, Leussink, Suzan, van der Klis, Fiona R M, de Melker, Hester E, van der Sande, Marianne A B, Hoebe, Christian J P A, Bogaards, Johannes A
Veröffentlicht in: Woestenberg , P J , King , A J , van Benthem , B H B , Donken , R , Leussink , S , van der Klis , F R M , de Melker , H E , van der Sande , M A B , Hoebe , C J P A , Bogaards , J A & Medical Microbiological Laboratories and the Public Health Services 2018 , ' Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity : Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors ' , The Journal of Infectious Diseases , vol. 217 , no. 2 , pp. 213-222 . https://doi.org/10.1093/infdis/jix582;
2018
Veröffentlicht in: Woestenberg , P J , King , A J , van Benthem , B H B , Donken , R , Leussink , S , van der Klis , F R M , de Melker , H E , van der Sande , M A B , Hoebe , C J P A , Bogaards , J A & Medical Microbiological Laboratories and the Public Health Services 2018 , ' Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity : Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors ' , The Journal of Infectious Diseases , vol. 217 , no. 2 , pp. 213-222 . https://doi.org/10.1093/infdis/jix582;
2018
45
Simons, Joost J. M., Vida, Nora, Westra, Tjalke A., Postma, Maarten J.
Veröffentlicht in: Simons , J J M , Vida , N , Westra , T A & Postma , M J 2020 , ' Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands ' , Vaccine , vol. 38 , no. 30 , pp. 4687-4694 . https://doi.org/10.1016/j.vaccine.2020.05.031;
2020
Veröffentlicht in: Simons , J J M , Vida , N , Westra , T A & Postma , M J 2020 , ' Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands ' , Vaccine , vol. 38 , no. 30 , pp. 4687-4694 . https://doi.org/10.1016/j.vaccine.2020.05.031;
2020
46
47
48
Setiawan, Didik, Luttjeboer, Jos, Westra, Tjalke Arend, Wilschut, Jan C., Suwantika, Auliya A., Daemen, Toos, Atthobari, Jarir, Wilffert, Bob, Postma, Maarten J.
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015
49
50